Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Amylyx Pharmaceuticals, Inc. | StockGist | StockGist

Companies
AMLX
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings AMLXSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Amylyx Pharmaceuticals, Inc.

Filed Oct 30, 2025

Accepted Oct 29, 2025, 8:00 PM ET

CIK 0001658551

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Amylyx Pharmaceuticals, Inc.

Person Type

IA

CUSIP: 03237H101

Amendment History

10 filings

SCHEDULE 13G
Original
Oct 7, 20250000315066-25-002303
SCHEDULE 13G/A
Amendment 1
Feb 14, 20250000950170-25-021226
SCHEDULE 13G/A
Amendment 2
Feb 14, 20250000950170-25-021288
SCHEDULE 13G/A
Amendment 3
May 15, 20250000950170-25-072740
SCHEDULE 13G/A
Amendment 4
May 15, 20250000902664-25-002375
SCHEDULE 13G/A
Amendment 5
Aug 12, 20250000902664-25-003514
SCHEDULE 13G/A
Amendment 6
Viewing
Oct 30, 20250000102909-25-000074
SCHEDULE 13G/A
Amendment 7
Nov 13, 20250000902664-25-004887
SCHEDULE 13G/A
Amendment 8
Nov 14, 20250000902664-25-005011
SCHEDULE 13G/A
Amendment 9
Latest
Nov 14, 20250001193125-25-282838

Recent Filings

Amylyx Pharmaceuticals, Inc.1 weeks ago

Amylyx Pharmaceuticals, Inc.1 months ago

Amylyx Pharmaceuticals, Inc.1 months ago

Amylyx Pharmaceuticals, Inc.1 months ago

Amylyx Pharmaceuticals, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice